Physiological Responses to Heat Stress During High-risk Events
1 other identifier
observational
150
1 country
2
Brief Summary
Exertional heat stroke (EHS) affects \~500 Military Personnel and over 100 Soldiers every year, and it is believed that these numbers are underreported. EHS is the most severe form of exertional heat illness (EHI) and can result in substantial, long-lasting organ damage, and even death in severe cases. Based on current knowledge and training needs, it is impossible to prevent every EHS - which shifts the focus from exclusively prevention to a combination of prevention, treatment, and enhancing recovery as much as possible. While many risk factors have been identified and there are adequate treatments available, biomarkers associated with heat stroke risk, recovery, and return-to-duty (RTD) remain largely unclear. The purpose of the proposed study is to enhance knowledge surrounding biomarkers of EHS and long-term health consequences that result from EHS. The investigators will recruit research volunteers for a field study in order to collect pre-, post-, and follow-up measures from a high-risk EHS event (i.e. ruck marches, timed runs) this will allow us to have a basis for comparison between Soldiers who collapse with EHS (from previously collected data) and those that complete high-risk events, but do not collapse. This will allow for comparison between the groups to identify EHS-specific biomarkers that could aid in recovery and RTD decisions for Soldiers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 2, 2025
CompletedStudy Start
First participant enrolled
May 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
ExpectedMay 5, 2026
April 1, 2026
4 months
March 24, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Core temperature
Body temperature recorded during training
Collected only during training, pre-exercisce, post-exercise, and after recovery (from 0-36 hours)
Creatinine from blood serum
Serum creatinine measures to evaluate kidney function
Measured at least once every 6 hours for up to 36 hours
Alanine aminotransferase from blood samples
Measure of liver function (ALT) from blood
Measured at least once every 6 hours for up to 36 hours
Aspartate aminotransferase (AST)
Liver function measure (AST) from blood
Measured at least once every 6 hours for up to 36 hours
Heart rate
Heart rate measured during activity
Measured during training only from start of training up to completion (~4 hours)
Secondary Outcomes (3)
Urinary KIM-1
Measured at least once every 6 hours for up to 36 hours
Urinary creatinine
Measured at least once every 6 hours for up to 36 hours
Blood sodium concentration
Measured at least once every 6 hours for up to 36 hours
Interventions
None - observational study
Eligibility Criteria
The sample population included in this investigation will be that of Soldiers undergoing high-risk training events in military training. There are no gender, race, or ethnicity limitations.
You may qualify if:
- Individuals (to include cis- and transgender males and females and nonbinary) 18 years of age or greater
- Current military service (active, Reserve, or National Guard)
- Currently participating in training
You may not qualify if:
- Females who are pregnant
- Any individual currently on a physical profile that restricts running or foot marching
- History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
- Scheduled MRI within 2 weeks after core temp pill ingestion
- Known allergies to skin adhesive
- Blood donation in the past 8 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Fort Novosel
Fort Novosel, Alabama, 36362, United States
Field Study
Fort Jackson, South Carolina, 29207, United States
Related Publications (2)
Roberts WO, Armstrong LE, Sawka MN, Yeargin SW, Heled Y, O'Connor FG. ACSM Expert Consensus Statement on Exertional Heat Illness: Recognition, Management, and Return to Activity. Curr Sports Med Rep. 2021 Sep 1;20(9):470-484. doi: 10.1249/JSR.0000000000000878.
PMID: 34524191BACKGROUNDWilliams VF, Oh GT. Update: Heat illness, active component, U.S. Armed Forces, 2021. MSMR. 2022 Apr 1;29(4):8-14.
PMID: 35608520BACKGROUND
Biospecimen
Blood and urine samples (without DNA) will be retained for biological analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Physiologist
Study Record Dates
First Submitted
March 24, 2025
First Posted
April 2, 2025
Study Start
May 31, 2025
Primary Completion
September 30, 2025
Study Completion (Estimated)
September 1, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Not permitted to share as Army data